Gemcitabine and Cisplatin Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Carcinoma: Predicting Response and Assessing Outcomes

Urologic Oncology: Seminars and Original Investigations - United States
doi 10.1016/j.urolonc.2015.02.011
Full Text
Abstract

Available in full text

Categories
OncologyUrology
Date
Authors
Publisher

Elsevier BV

Related search

Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder

Japanese Journal of Urology
Urology
2015English

Mp49-16 Factors Predicting Failure to Follow Pre-Scheduled Gemcitabine Plus Cisplatin Chemotherapy Regimen for Urothelial Carcinoma

Journal of Urology
Urology
2016English

Triplet Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin as Second-Line Therapy for Advanced Urothelial Carcinoma

Modern Chemotherapy
2013English

Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2020English

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin‐Ineligible Patients With Muscle‐Invasive Localized Urothelial Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

The Ratio of CD8 to Treg Tumor-Infiltrating Lymphocytes Is Associated With Response to Cisplatin-Based Neoadjuvant Chemotherapy in Patients With Muscle Invasive Urothelial Carcinoma of the Bladder

OncoImmunology
OncologyAllergyImmunology
2016English

Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer

Urology
Urology
2017English

Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy